International Journal of Phytomedicine and Phytotherapy
From: The potential of silymarin for the treatment of hepatic disorders
Study | Silymarin | Control | Weighta | WMD (fixed) | ||
---|---|---|---|---|---|---|
 | N | Mean (SD) | N | Mean (SD) | % | 95 % CI |
DiMario et al., 1981 [70] | 15 | 25.40 (15.60) | 14 | 50.60 (24.30) | 3.38 | −25.20 [−40.18, −10.22] |
Salmi et al., 1982 [71] | 47 | 38.20(15.99) | 50 | 51.20(24.99) | 11 | −13.00 [−21.30, −4.70] |
Feher et al., 1989 [72] | 17 | 22.80(5.10) | 19 | 31.30(4.50) | 76.01 | −8.50 [−11.66, −5.34] |
Müzes et al., 1990 [73] | 10 | 28.00(11.00) | 20 | 52.00(13.00) | 9.6 | −24.00 [−32.88, −15.12] |
Total (95 % CI) | 89 |  | 103 |  | 100 | −11.05 [−13.80, −8.29] |